M0430
Methyl cellulose
26.0-33.0% (methoxyl group, on Dry Basis), meets USP testing specifications, viscosity: 400 cP
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Recommended Products
Agency
USP/NF
meets USP testing specifications
Quality Level
Assay
26.0-33.0% (methoxyl group, on Dry Basis)
form
powder
useful pH range
5.0-8.0 (2% in water)
viscosity
320-480 cP, 2 % in water(20 °C)
application(s)
pharmaceutical (small molecule)
SMILES string
[*]OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO[*])O[C@@H](O[*])[C@H](O[*])[C@H]2O[*])[C@H](O[*])[C@@H](O[*])[C@@H]1O[*]
InChI key
YLGXILFCIXHCMC-JHGZEJCSSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
Methyl cellulose is an odorless and tasteless material. It is tough and non-toxic. Due to these properties, methyl cellulose is used as an adhesive in the food packaging industry. In water-soluble adhesives, it is utilized as a thickening agent.
Application
Methyl cellulose has been used as a supplement of Mammacult media for mammosphere culture from SUM159 TN breast cancer cells. It has also been used to formulate drugs such as ITI-007 and PCC0104005 to characterize their functional activity.
Other Notes
To gain a comprehensive understanding of our extensive range of Polysaccharides for your research, we encourage you to visit our Carbohydrates Category page.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission
Snyder GL, et al.
Psychopharmacology, 232(3), 605-621 (2015)
In Vitro and In Vivo Characterization of PCC0104005, a Novel Modulator of Serotonin-Dopamine Activity, as an Atypical Antipsychotic Drug
Xu Y,et al.
Scientific Reports, 8(1), 6892-6892 (2018)
Yanan Xu et al.
Scientific reports, 8(1), 6892-6892 (2018-05-04)
PCC0104005 is a novel drug candidate for treating schizophrenia that displays high affinity for serotonin, dopamine, and noradrenaline receptors, including partial agonism at dopamine D2, D3, D4, serotonin 5-HT1A, and 5-HT2A receptors and antagonism at 5-HT2B, 5-HT6, and 5-HT7 receptors.
Handbook of Adhesives and Surface Preparation (2011)
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
Li S, et al.
Breast Cancer Research, 17(1), 91-91 (2015)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service